据报道,大多数β-肾上腺能受体阻滞剂均有可能导致药物性肝炎。但迄今尚未见人报道,具有内源性拟交感活性的心脏肾上腺能受体阻滞剂—醋丁酰心安引起的肝损害。美国食品和药物管理局下设的流行病和卫生监督分部自1985年以来,已先后收到了 It has been reported that most β-adrenergic receptor blockers are likely to cause drug-induced hepatitis. However, up to now, there is no report about hepatic damage caused by acebutanophenone, a cardiac adrenergic receptor blocker with endogenous sympathomimetic activity. The Epidemic and Health Surveillance Division of the Food and Drug Administration in the United States has received